BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29934595)

  • 21. Tangeretin regulates platelet function through inhibition of phosphoinositide 3-kinase and cyclic nucleotide signaling.
    Vaiyapuri S; Ali MS; Moraes LA; Sage T; Lewis KR; Jones CI; Gibbins JM
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2740-9. PubMed ID: 24135020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action.
    Sugidachi A; Breiter N; Ogawa T; Asai F; Koike H
    Thromb Haemost; 1996 Nov; 76(5):786-90. PubMed ID: 8950791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological actions of nobiletin in the modulation of platelet function.
    Vaiyapuri S; Roweth H; Ali MS; Unsworth AJ; Stainer AR; Flora GD; Crescente M; Jones CI; Moraes LA; Gibbins JM
    Br J Pharmacol; 2015 Aug; 172(16):4133-45. PubMed ID: 25988959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel Therapeutic Agent against Platelet Activation In Vitro and Arterial Thrombosis In Vivo by Morin Hydrate.
    Hsia CW; Wu MP; Velusamy M; Hsia CH; Chou DS; Tsai CL; Hsu CY; Jayakumar T; Chung CL; Sheu JR
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30104547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet ADP receptors and their antagonists.
    Benoit P; Dogné JM
    Mini Rev Med Chem; 2003 Mar; 3(2):145-8. PubMed ID: 12570847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible Molecular Targets of Novel Ruthenium Complexes in Antiplatelet Therapy.
    Jayakumar T; Hsu CY; Khamrang T; Hsia CH; Hsia CW; Manubolu M; Sheu JR
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29925802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiparameter Evaluation of the Platelet-Inhibitory Effects of Tyrosine Kinase Inhibitors Used for Cancer Treatment.
    Tullemans BME; Veninga A; Fernandez DI; Aarts MJB; Eble JA; van der Meijden PEJ; Heemskerk JWM; Kuijpers MJE
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiplatelet Effects of Flavonoids Mediated by Inhibition of Arachidonic Acid Based Pathway.
    Karlíčková J; Říha M; Filipský T; Macáková K; Hrdina R; Mladěnka P
    Planta Med; 2016 Jan; 82(1-2):76-83. PubMed ID: 26393940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of in vitro studies of the anti-platelet potential of citrus fruit flavonoids.
    Olas B
    Food Chem Toxicol; 2021 Apr; 150():112090. PubMed ID: 33636212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thieno[2,3-b]pyridine derivatives are potent anti-platelet drugs, inhibiting platelet activation, aggregation and showing synergy with aspirin.
    Binsaleh NK; Wigley CA; Whitehead KA; van Rensburg M; Reynisson J; Pilkington LI; Barker D; Jones S; Dempsey-Hibbert NC
    Eur J Med Chem; 2018 Jan; 143():1997-2004. PubMed ID: 29129512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiplatelet Activity of a Newly Synthesized Novel Ruthenium (II): A Potential Role for Akt/JNK Signaling.
    Khamrang T; Hung KC; Hsia CH; Hsieh CY; Velusamy M; Jayakumar T; Sheu JR
    Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28448438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet-active substances in the venom of Bothrops moojeni snake-a novel evaluation method using whole blood aggregometry.
    Demler C; Bühler B; Menin L; Stöcklin R; Wilmer M; Ernst B; Perchuc AM
    Platelets; 2010; 21(1):20-8. PubMed ID: 19938887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiplatelet effect of differentially charged PEGylated lipid-polymer nanoparticles.
    Fuentes E; Yameen B; Bong SJ; Salvador-Morales C; Palomo I; Vilos C
    Nanomedicine; 2017 Apr; 13(3):1089-1094. PubMed ID: 27789259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro antiplatelet activity of extract and its fractions of Paulownia Clone in Vitro 112 leaves.
    Adach W; Żuchowski J; Moniuszko-Szajwaj B; Szumacher-Strabel M; Stochmal A; Olas B; Cieslak A
    Biomed Pharmacother; 2021 May; 137():111301. PubMed ID: 33561640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel naphthalimide derivative reduces platelet activation and thrombus formation via suppressing GPVI.
    Shih TL; Lin KH; Chen RJ; Chen TY; Kao WT; Liu JW; Wang HH; Peng HY; Sun YY; Lu WJ
    J Cell Mol Med; 2021 Oct; 25(19):9434-9446. PubMed ID: 34448532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and anti-platelet activity of obovatol derivatives.
    Kwak JH; Lee S; Park ES; In JK; Song J; Kim YJ; Choi NS; Lee H; Yun YP; Hong JT; Kwak YS; Min KH; Jung JK
    Arch Pharm Res; 2011 Jul; 34(7):1107-12. PubMed ID: 21811917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombotic activity of Vitis labrusca extract on rat platelet aggregation.
    Kwon SU; Lee HY; Xin M; Ji SJ; Cho HK; Kim DS; Kim DK; Lee YM
    Blood Coagul Fibrinolysis; 2016 Mar; 27(2):141-6. PubMed ID: 26340455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Esculetin, a Coumarin Derivative, Prevents Thrombosis: Inhibitory Signaling on PLCγ2-PKC-AKT Activation in Human Platelets.
    Hsia CW; Lin KC; Lee TY; Hsia CH; Chou DS; Jayakumar T; Velusamy M; Chang CC; Sheu JR
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31163690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and pharmacological evaluation of acylhydroquinone derivatives as potent antiplatelet agents.
    Méndez D; Donoso-Bustamante V; Pablo Millas-Vargas J; Pessoa-Mahana H; Araya-Maturana R; Fuentes E
    Biochem Pharmacol; 2021 Jan; 183():114341. PubMed ID: 33197432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of antiaggregatory activity of flavonoid aglycone series.
    Bojić M; Debeljak Z; Tomičić M; Medić-Šarić M; Tomić S
    Nutr J; 2011 Jul; 10():73. PubMed ID: 21745360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.